The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Open accessAbstract
Transforming growth factor β (TGF-β) is a secreted cytokine that regulates cell proliferation, migration, and the differentiation of a plethora of different cell types. Consistent with these findings, TGF-β plays a key role in controlling embryogenic development, inflammation, and tissue repair, as well as in maintaining adult tissue homeostasis. TGF-β elicits a broad range of context-dependent cellular responses, and consequently, alterations in TGF-β signaling have been implicated in many diseases, including cancer. During the early stages of tumorigenesis, TGF-β acts as a tumor suppressor by inducing cytostasis and the apoptosis of normal and premalignant cells. However, at later stages, when cancer cells have acquired oncogenic mutations and/or have lost tumor suppressor gene function, cells are resistant to TGF-β-induced growth arrest, and TGF-β functions as a tumor promotor by stimulating tumor cells to undergo the so-called epithelial-mesenchymal transition (EMT). The latter leads to metastasis and chemotherapy resistance. TGF-β further supports cancer growth and progression by activating tumor angiogenesis and cancer-associated fibroblasts and enabling the tumor to evade inhibitory immune responses. In this review, we will consider the role of TGF-β signaling in cell cycle arrest, apoptosis, EMT and cancer cell metastasis. In particular, we will highlight recent insights into the multistep and dynamically controlled process of TGF-β-induced EMT and the functions of miRNAs and long noncoding RNAs in this process. Finally, we will discuss how these new mechanistic insights might be exploited to develop novel therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
7 retracted
Items 201–242 of 242
XIST promotes gastric cancer (GC) progression through TGF‐β1 via targeting miR‐185
Zhang, Q., Chen, B., Liu, P., & Yang, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26447 · Cited by 73
Zhang, J., Han, C., Ungerleider, N., Chen, W., Song, K., Wang, Y., Kwon, H., Ma, W., & Wu, T. (2018) · Hepatology · doi:10.1002/hep.30153 · Cited by 73
Garrison, K., Hahn, T., Lee, W., Ling, L. E., Weinberg, A. D., & Akporiaye, E. T. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1119-y · Cited by 70
Sun, H., Miao, C., Liu, W., Qiao, X., Yang, W., Li, L., & Li, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.104 · Cited by 70
Sha, X., Yang, L., & Gentry, L. E. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.4.827 · Cited by 69
Zhang, Y., He, R., Dang, Y., Zhang, X., Wang, X., Huang, S., Huang, W., Jiang, M., Gan, X., Xie, Y., et al. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0366-6 · Cited by 68
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers
Olsen, S. N., Wronski, A., Castaño, Z., Dake, B. T., Malone, C. F., Raedt, T. D., Enos, M., DeRose, Y. S., Zhou, W., Guerra, S. L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0520 · Cited by 67
Imai, K., Minamiya, Y., Koyota, S., Ito, M., Saito, H., Sato, Y., Motoyama, S., Sugiyama, T., & Ogawa, J. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-3 · Cited by 66
Sjölund, J., Boström, A.-K., Lindgren, D., Manna, S., Moustakas, A., Ljungberg, B., Johansson, M., Fredlund, E., & Axelson, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023057 · Cited by 66
RNF8 promotes epithelial-mesenchymal transition of breast cancer cells
Kuang, J., Li, L., Guo, L., Su, Y., Wang, Y., Xu, Y., Wang, X., Meng, S.-C., Lei, L., Xu, L., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0363-6 · Cited by 64
Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β
Wiener, Z., Band, A. M., Kallio, P., Högström, J., Hyvönen, V., Kaijalainen, S., Ritvos, O., Haglund, C. H., Kruuna, O., Robine, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406444111 · Cited by 63
Yu, F., Wang, J., Wu, F., Song, Y., Zhao, S., & Zhang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17552 · Cited by 63
Diepenbruck, M., Tiede, S., Saxena, M. T., Ivánek, R., Kalathur, R. K. R., Lüönd, F., Meyer‐Schaller, N., & Christofori, G. (2017) · Nature Communications · doi:10.1038/s41467-017-01197-w · Cited by 63
Qu, S., Yang, X., Song, W., Sun, W., Li, X., Wang, J., Zhong, Y., Shang, R., Ruan, B., Zhang, Z., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4252-y · Cited by 62
Jin, Y., Cui, Z., Li, X., Jin, X., & Peng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15318 · Cited by 62
Werden, S. J., Sphyris, N., Sarkar, T. R., Paranjape, A. N., LaBaff, A. M., Taube, J. H., Hollier, B. G., Ramirez‐Peña, E., Soundararajan, R., den Hollander, P., et al. (2016) · Oncogene · doi:10.1038/onc.2016.203 · Cited by 61
4E‐BP1 is a target of Smad4 essential for TGFβ‐mediated inhibition of cell proliferation
Azar, R., Alard, A., Susini, C., Bousquet, C., & Pyronnet, S. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.291 · Cited by 60
Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition
Expósito, A., Aránega, A. E., & Franco, D. (2018) · Non-Coding RNA · doi:10.3390/ncrna4020014 · Cited by 60
Ozaki, I., Hamajima, H., Matsuhashi, S., & Mizuta, T. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00078 · Cited by 58
Ling, M. T., Wang, X., Tsao, S. W., & Wong, Y. C. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00189-7 · Cited by 55
Hao, Y., Yang, X., Zhang, D., Luo, J., & Chen, R. (2017) · Gene · doi:10.1016/j.gene.2017.01.023 · Cited by 55
Self-citationEvanno, E., Godet, J., Piccirilli, N., Guilhot, J., Milin, S., Gombert, J. M., Fouchaq, B., & Roche, J. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0380-0 · Cited by 55
Cf, Q., & Fl, Z. (2017) · PubMed · Cited by 54
Chen, L., Li, Y., Wu, L., Yu, G., Zhang, W., Huang, C., & Sun, Z. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13439 · Cited by 53
Li, Z., Liu, H., Zhong, Q., Wu, J., & Tang, Z. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12533 · Cited by 52
Zhang, Y., Li, J., Shi, J., Wang, Y., Kang, Y., & Zhang, W. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0168 · Cited by 52
Pinto, M., Oliveíra, C., Cirnes, L., Machado, J. C., RAMIRES, M., Nogueira, A., Carneiro, F., & Seruca, R. (2003) · The Journal of Pathology · doi:10.1002/path.1327 · Cited by 51
miRNAs, Melanoma and Microenvironment: An Intricate Network
Romano, G., & Kwong, L. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112354 · Cited by 49
Deng, Y., Zhao, F., Zhang, Z., Sun, F., & Wang, M. (2018) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2018.2503 · Cited by 48
Rodríguez-Mateo, C., Torres, B., Gutiérrez, G., & Pintor‐Toro, J. A. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.9 · Cited by 46
Li, Y., Liu, G., Li, X., Dong, H., Xiao, W., & Lu, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.047 · Cited by 46
Cassar, L., Nicholls, C., Pinto, A. R., Chen, R., Wang, L., Li, H., & Liu, J. (2016) · Protein & Cell · doi:10.1007/s13238-016-0322-1 · Cited by 44
lncRedibly versatile: biochemical and biological functions of long noncoding RNAs
Shields, E. J., Petracovici, A., & Bonasio, R. (2019) · Biochemical Journal · doi:10.1042/bcj20180440 · Cited by 44
Han, Q., Zhang, W., Meng, J., Ma, L., & Li, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.162 · Cited by 43
Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma
Zhang, R., Hardin, H. A., Huang, W., Buehler, D. G., & Lloyd, R. V. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9507-2 · Cited by 40
Groppa, E., Brkić, Š., Bovo, E., Reginato, S., Sacchi, V., Maggio, N. D., Muraro, M. G., Calabrese, D., Heberer, M., Giannì-Barrera, R., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201405003 · Cited by 38
Liu, Y., Qian, J., Li, X., Chen, W., Xu, A., Zhao, K., Hua, Y., Huang, Z., Zhang, J., Liang, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12937 · Cited by 38
MicroRNAs and signaling networks involved in epithelial–mesenchymal transition
Shenas, M. H. M., Eghbal‐Fard, S., Mehrisofiani, V., Yazdani, N. A., Farzam, O. R., Marofi, F., & Yousefi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27489 · Cited by 36
Akbari, A., Amanpour, S., Muhammadnejad, S., Ghahremani, M. H., Ghaffari, S. H., Dehpour, A. R., Mobini, G. R., Shidfar, F., Abastabar, M., Khoshzaban, A., et al. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-47 · Cited by 33
MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma
Zhang, S. Z., Cai, L., & Li, B. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2017_121 · Cited by 31
Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies
Baghdassarian, N., & Ffrench, M. (1996) · Hematology and Cell Therapy · doi:10.1007/s00282-996-0313-4 · Cited by 21
Doi, T., Lee, K., Kim, T., Ohtsu, A., Kim, T. Y., Ikeda, M., Yoh, K., Stampino, C. G., Hirohashi, T., Suzuki, A., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.724 · Cited by 16
Cited by
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.819128 · Cited by 763
Dynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Metadata
- Authors
- Hao, Y., Baker, D., & ten Dijke, P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-06-05
- Volume
- 20
- Issue
- 11
- Pages
- 2767
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2948368848
- Cited by
- 1,142
- References
- 242
- FWCI
- 34.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.